|
SPOP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.563400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.056000E-01 |
| Normal-vs-Stage2 |
3.341600E-01 |
| Normal-vs-Stage3 |
3.957600E-02 |
| Normal-vs-Stage4 |
1.104180E-02 |
| Stage1-vs-Stage2 |
1.400230E-01 |
| Stage1-vs-Stage3 |
6.364400E-03 |
| Stage1-vs-Stage4 |
2.180200E-03 |
| Stage2-vs-Stage3 |
6.619000E-01 |
| Stage2-vs-Stage4 |
4.142200E-01 |
| Stage3-vs-Stage4 |
5.654000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.140000E-01 |
| Normal-vs-AfricanAmerican |
3.408600E-01 |
| Normal-vs-Asian |
2.575800E-01 |
| Caucasian-vs-AfricanAmerican |
7.866000E-01 |
| Caucasian-vs-Asian |
5.294000E-02 |
| AfricanAmerican-vs-Asian |
7.279800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.598570E-01 |
| Normal-vs-Female |
7.089400E-01 |
| Male-vs-Female |
2.677000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.379200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.720000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.041210E-01 |
| Normal-vs-Age(81-100Yrs) |
6.113700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.912800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.927800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.037800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.775600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.758300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.930240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.675800E-03 |
| Normal-vs-Grade 2 |
4.677200E-01 |
| Normal-vs-Grade 3 |
1.867870E-02 |
| Normal-vs-Grade 4 |
1.068070E-02 |
| Grade 1-vs-Grade 2 |
5.876200E-03 |
| Grade 1-vs-Grade 3 |
5.74269999999988E-05 |
| Grade 1-vs-Grade 4 |
7.65980000000388E-05 |
| Grade 2-vs-Grade 3 |
8.208900E-04 |
| Grade 2-vs-Grade 4 |
1.261500E-03 |
| Grade 3-vs-Grade 4 |
3.773000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.995500E-02 |
| Normal-vs-ccB subtype |
8.016100E-03 |
| ccA subtype-vs-ccB subtype |
1.6666000000054E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.890600E-01 |
| Normal-vs-N1 |
1.523800E-01 |
| N0-vs-N1 |
3.137800E-01 |
|
|
